KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.96

Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men.

Joel M Palefsky, Anna R Giuliano, Stephen E Goldstone, Brady Dubin, Alfred Saah, Alain Luxembourg, Christine Velicer, Joseph E Tota

Clin Infect Dis 82(3) e616-e625

PMID41162330
PMCIDPMC13016981
DOI10.1093/cid/ciaf584
发表日期2025-10-29
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 2 张 PMC Figure,均未识别为 KM 图:Figure 1.:非 KM 图;Figure 2.:非 KM 图。
摘要

摘要

BACKGROUND: Critical gaps exist in our understanding of the progression from anal human papillomavirus (HPV) infection to same-type HPV-associated anal disease in human immunodeficiency virus (HIV)-negative men who have sex with men (MSM). We conducted a post hoc analysis of a phase 3 randomized 4-valent HPV vaccine trial (NCT00090285) to assess the natural progression of anal HPV infections to associated anal lesions among MSM. PARTICIPANTS: A total of 602 HIV-negative MSM aged 16-27 years. METHODS: HIV-negative MSM aged 16-27 years enrolled in the placebo arm from 18 countries were included. We estimated the distribution of 9-valent HPV (9vHPV) vaccine types in intra-anal lesions (anal condyloma and anal intraepithelial neoplasia [AIN] 1-3), proportions and rates of progression from incident-persistent (no associated anal disease at baseline) intra-anal HPV infections to the same-type HPV-associated anal lesion, and cumulative incidence over 30 months. RESULTS: Predominant 9vHPV types detected were HPV6 (55.7%) and HPV11 (25.3%) in MSM with anal condyloma/AIN1, and HPV6 (30.5%), HPV16 (22.0%), and HPV11 (15.3%) in those with pooled AIN2/3. Progression from incident-persistent intra-anal 9vHPV infection to anal disease was driven primarily by HPV6, HPV11, and HPV16/18 infections for MSM with anal condyloma/AIN1 (63.0%, 85.7%, and 16.3%, respectively) and AIN2/3 (25.9%, 14.3%, and 32.4%, respectively). Cumulative incidence of anal condyloma/AIN1 and AIN2/3 in MSM with incident-persistent infection was 43.1% and 34.4%, respectively. CONCLUSIONS: A high proportion of unvaccinated HIV-negative MSM with a new intra-anal 9vHPV infection developed same-type HPV-associated anal disease. These findings support HPV vaccination of young HIV-negative MSM to prevent anal HPV infection and associated anal disease. REGISTRATION: ClinicalTrials.gov, NCT00090285.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(2,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1.Kaplan–Meier estimates for the cumulative incidence of progression from incident-persistent ( A ) or prevalent-persistent ( B ) anal HPV infections a with 9vHPV types (6/11/16/18/31/33/45/52/58) based on swab sampling, to anal condyloma/AIN1 among MSM (HNRT population b ) associated with the same HPV type. 9vHPV, 9-valent HPV; AIN, anal intraepithelial neoplasia; HNRT, HPV naive to relevant type; HPV, human papillomavirus; MSM, men who have sex with men; PCR, polymerase chain reaction. a Infection with ≥1 9vHPV type. b HNRT population defined as HPV naive at day 1 to the HPV type under consideration. For HPV6, HPV11, HPV16, and HPV18, HPV naive was defined as having a negative swab (ie, PCR negative) and serology negative to the relevant HPV type. For HPV31, HPV33, HPV45, HPV52, and HPV58, HPV naive was defined as having a negative swab to the relevant HPV type.
非 KM Figure
Figure 2.Kaplan–Meier estimates for the cumulative incidence of progression from incident-persistent ( A ) or prevalent-persistent ( B ) anal HPV infections with 9vHPV types (6/11/16/18/31/33/45/52/58) based on swab sampling, to AIN2 or AIN3 among MSM (HNRT population a ) associated with the same HPV type. 9vHPV, 9-valent HPV; AIN, anal intraepithelial neoplasia; HNRT, HPV naive to relevant type; HPV, human papillomavirus; MSM, men who have sex with men; PCR, polymerase chain reaction. a HNRT population defined as HPV naive at day 1 to the HPV type under consideration. For HPV6, HPV11, HPV16, and HPV18, HPV naive was defined as having a negative swab (ie, PCR negative) and serology negative to the relevant HPV type. For HPV31, HPV33, HPV45, HPV52, and HPV58, HPV naive was defined as having a negative swab to the relevant HPV type.
非 KM Figure